Postremission sequential monitoring of minimal residual disease by WT 1 Q‐ PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients-Reference-Cited by-同舟云学术

Postremission sequential monitoring of minimal residual disease by WT 1 Q‐ PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients

Published:2015-12-29 Issue:2 Volume:5 Page:265-274
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Malagola Michele¹,Skert Cristina¹,Borlenghi Erika²,Chiarini Marco³,Cattaneo Chiara²,Morello Enrico²,Cancelli Valeria¹,Cattina Federica¹,Cerqui Elisa¹,Pagani Chiara¹,Passi Angela¹,Ribolla Rossella¹,Bernardi Simona¹³,Giustini Viviana³,Lamorgese Cinzia²,Ruggeri Giuseppina⁴,Imberti Luisa³,Caimi Luigi³⁴,Russo Domenico¹,Rossi Giuseppe²

Affiliation:

1. Unit of Blood Disease and Stem Cell Transplantation Department of Clinical and Experimental Sciences University of Brescia AO Spedali Civili di Brescia Brescia Italy

2. Division of Hematology AO Spedali Civili di Brescia Brescia Italy

3. Centro di Ricerca Emato‐oncologica AIL (CREA) Brescia AO Spedali Civili di Brescia Brescia Italy

4. Laboratorio Analisi Department of Molecular and Translational Medicin University of Brescia AO Spedali Civili di Brescia Brescia Italy

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.593

Reference46 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

2. Treatment of acute myeloid leukemia: are we making progress?;Burnett A. K;Hematology,2012